Rational immunotherapy in the combination treatment of community-acquired pneumonia

Медицинский совет

R. M. Fazlyeva¹  G. A. Mavzyutova¹  L. R. Mukhamadieva¹  G. K. Mirsaeva¹  E. B. Tyurina² 

[1] Bashkir State Medical University, Russia's Ministry of Health;City Clinical Hospital №5, Ufa;

关键词: внебольничная пневмония;    иммунокоррекция;    иммунопатогенез;    азоксимера бромид (полиоксидоний);    community-acquired pneumonia;    immunotherapy;    immunopathogenesis;    azoximer bromide (polyoxidonium);   

DOI  :  10.21518/2079-701X-2015-16-68-73

来源: DOAJ

【 摘 要 】

The article analyzes the immunomodulatory therapy as part of pathogenetic treatment of community-acquired pneumonia. Immunological monitoring of patients with severe community-acquired pneumonia demonstrated a disbalance of natural resistance factors, cellular component of immune system and humoral stress factor, which required immunotherapy. Immunomodulatory therapy included azoximer bromide (Polyoxidonium) according to the prescribed regimen and demonstrated immunological efficacy.

【 授权许可】

Unknown